Organization
Simon Williamson Clinic
1 clinical trial
Clinical trial
Akynzeo or Olanzapine for Patients Who Experience Breakthrough CINV in Patient Receiving Moderately or Highly Emetogenic Chemotherapy After First Cycle of ChemotherapyStatus: Recruiting, Estimated PCD: 2023-12-31